About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life.
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and ...
A KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took them, with many ...
A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
The number of adolescents and young adults prescribed a glucagon-like peptide-1 (GLP-1) receptor agonist increased nearly 600 ...
KFF poll results suggest about 12 percent of adults in the U.S. have tried a GLP-1 drug like Ozempic to manage chronic health ...
Most adults (62%) say they have taken a GLP-1 drug to treat a chronic condition including diabetes or heart disease, while 43 ...
The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly ...
About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people – are ...
(Reuters) – About one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight loss and related conditions, a poll by Kaiser Family Foundation (KFF) showed on Friday.